Saba Capital Management, L.P. bought HQL
April 26, 2024 · Form 4 insider transaction
Saba Capital Management, L.P. bought 120,304 shares of Abrdn Life Sciences Investors at $13.00 per share, a transaction worth $1.56M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
120,304
Price
$13.00
Total value
$1.56M
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateApril 26, 2024
Filing dateApril 29, 2024
Shares owned after3,025,602
OwnershipIndirect
10b5-1 planNo
AmendedNo